News

Positrigo Secures CE Mark in Europe for its Pioneering Dedicated Brain PET System

October 2, 2024
Positrigo secures CE Mark in Europe for NeuroLF System

Positrigo Receives FDA Clearance for Breakthrough Brain PET System

July 16, 2024
NeuroLF now FDA cleared and available for sale in the US.

NeuroLF brain images presented first time

April 4, 2024
First brain images from the NeuroLF system were presented at the ECCN conference.

Positrigo opens US subsidiary to benefit from promising market developments

October 16, 2023
Positrigo opens US subsidiary to benefit from promising market developments

Positrigo presents NeuroLF first time

September 13, 2023
Unveiling of NeuroLF System at EANM 2023 in Vienna

Preliminary Performance Data of NeuroLF – Prof. Simon Cherry new Advisory Board Member

June 8, 2023
Positrigo appoints Prof. Simon Cherry as Advisory Board member and reports preliminary performance data of NeuroLF

Positrigo receives Swiss Accelerator grant

May 3, 2023
Positrigo receives Swiss Accelerator grant from Innosuisse

2022 Review

December 29, 2022
Positrigo reflects on a successful Year.

Proof-of-Concept Publication in Journal of Imaging

December 21, 2022
Positrigo team co-authors proof-of-concept study

Positrigo closes successfully Series B Funding Round.

October 24, 2022
Positrigo receives CHF 5.5 million in Series B funding round.

This website uses cookies to provide services and analyze access. read more